Bactericidal Activity of Rifampin-Amikacin against Mycobacterium ulcerans in Mice

To identify the most active curative treatment of Buruli ulcer, two regimens incorporating the use of rifampin (RIF) were compared with the use of RIF alone in a mouse footpad model of Mycobacterium ulcerans infection. Treatments began after footpad swelling from infection and continued for 12 weeks...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Dega, Herve, Bentoucha, Abdelhalim, Robert, Jerome, Jarlier, Vincent, Grosset, Jacques
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2002
Soggetti:	Experimental Therapeutics
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC128793/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12234844/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.10.3193-3196.2002
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!